Healthcare Providers and Services
Company Overview of Prestige Brands, Inc.
Prestige Brands, Inc. markets, sells, and distributes over-the-counter healthcare and household cleaning products to retail outlets in the United States, Canada, and internationally. The company offers healthcare and personal care products, including denture cleansers, denture adhesives, allergen blocks, throat drops, nasal sprays, scar fades, headache powders, dietary supplements, lip balms, earwax removers, pain relievers, sleep aids, wart treatments, dental protectors, antacids, eye drops, and shampoos; and gas treatment, liquid bandage, oral care, motion sickness treatment, feminine hygiene washing, homeopathic, sore throat/oral anesthetic, and pediatric over-the-counter healthcare produ...
90 North Broadway
Irvington, NY 10533
Key Executives for Prestige Brands, Inc.
Vice President of Operations
Senior Vice President of International
Senior Vice President of Science & Technology
Compensation as of Fiscal Year 2012.
Prestige Brands, Inc. Key Developments
Prestige Brands Holdings, Inc. and Prestige Brands, Inc. Announce Amendment to its Term Loan Credit Agreement
Feb 25 13
On February 21, 2013, Prestige Brands Holdings, Inc. and its subsidiary, Prestige Brands, Inc. entered into Amendment to the Term Loan Credit Agreement dated as of January 31, 2012, among the Borrower, the company, the other guarantors from time to time party thereto, each lender from time to time party thereto and Citibank, N.A., as administrative agent. The Amendment provides for the refinancing of all of the Borrower’s existing Term B Loans under the Credit Agreement with new Term B-1 Loans. The interest rate on the Term B-1 Loans is based, at the Borrower’s option, on a LIBOR rate, plus a margin of 2.75% per annum, with a LIBOR floor of 1.00%, or an alternate base rate, plus a margin. The new Term B-1 Loans will mature on the same date as the Term B Loans original maturity date. In addition, the Amendment provides the Borrower with certain additional capacity to prepay subordinated debt, its existing 8.125% senior unsecured notes due 2020 and certain other unsecured indebtedness permitted to be incurred under the Credit Agreement.
Prestige Brands, Inc. Issues $250 Million in Aggregate Principal Amount of 8.125% Senior Notes Due 2020
Feb 2 12
On January 31, 2012, Prestige Brands Holdings, Inc. announced that its wholly-owned subsidiary, Prestige Brands, Inc., issued $250 million in aggregate principal amount of 8.125% Senior Notes due 2020. The Notes were issued pursuant to an Indenture, dated as of the Closing Date, among Prestige Brands, the Company, as a guarantor, and certain other subsidiaries of the Company, as guarantors, and U.S. Bank National Association, as trustee, and a Registration Rights Agreement, dated as of the Closing Date, among Prestige Brands, the Company, certain other subsidiaries of the Company, as guarantors, and Morgan Stanley & Co., LLC, Citigroup Global Markets Inc., RBC Capital Markets, LLC and Deutsche Bank Securities Inc.
Prestige Brands, Inc. Announces Pricing of $250 Million Senior Notes Due 2020
Jan 25 12
Prestige Brands Holdings, Inc. announced that Prestige Brands, Inc. has priced an offering of $250 million in aggregate principal amount of 8.125% senior notes due 2020. The sale of the Notes is expected to be completed on or about January 31, 2012, subject to customary closing conditions. At such time, subject to customary closing conditions, the Company expects to complete the previously announced acquisition of certain North American over-the-counter healthcare brands owned by GlaxoSmithKline plc and its affiliates, to enter into new senior secured credit facilities (including a new term loan facility) and secure Prestige Brands' existing 8.25% Senior Notes due 2018 ratably with the new term loan facility. The Notes will be senior unsecured obligations of Prestige Brands and will be guaranteed by the Company and certain of its domestic subsidiaries. The Company intends to use the net proceeds from the offering, together with borrowings under the new senior secured credit facilities, to finance the GSK Brands Acquisition, to repay its existing senior secured credit facilities, to pay fees and expenses incurred in connection with these transactions and for general corporate purposes. The Notes and related guarantees are being offered only to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended or, outside the United States, to persons other than "U.S. persons" in compliance with Regulation S under the Securities Act. This press release does not constitute an offer to sell or the solicitation of an offer to buy the Notes and related guarantees. Any offers of the Notes and related guarantees will be made only by means of a private offering memorandum. The Notes and related guarantees have not been registered under the Securities Act, or the securities laws of any other jurisdiction, and may not be offered or sold in the United States without registration or an applicable exemption from registration requirements.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|